Interleukin-17 increases the expression of Toll-like receptor 3 via the STAT3 pathway in rheumatoid arthritis fibroblast-like synoviocytes

Immunology

Volumn 141, Issue 3, 2014, Pages 353-361

  Lee, Seon Yeong ^a   Yoon, Bo Young ^b   Kim, Ju In ^c   Heo, Yang Mi ^a   Woo, Yun Ju ^a   Park, Sung Hwan ^a   Kim, Ho Youn ^a   Kim, Sung Il ^c   Cho, Mi La ^a  

^a The Catholic University of Korea   (South Korea)

^b Inje University College of Medicine   (South Korea)

^c Pusan National University School of Medicine   (South Korea)

Author keywords

Human; Interleukin 17; Rheumatoid arthritis; Signal transducer and activator of transcription 3; Synovial fibroblasts; Toll like receptors

Indexed keywords

4 [[(4 METHYLPHENYL)SULFONYLOXY]ACETAMIDO]SALICYLIC ACID; INTERLEUKIN 17; INTERLEUKIN 23; MESSENGER RNA; STAT3 PROTEIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; FIBROBLAST LIKE SYNOVIOCYTE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MONOCYTE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; SYNOVIOCYTE; SYNOVIUM;

HUMAN; INTERLEUKIN-17; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 3; SYNOVIAL FIBROBLASTS; TOLL-LIKE RECEPTORS;

ADULT; AGED; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; CELLS, CULTURED; FIBROBLASTS; HUMANS; IMMUNITY, INNATE; INTERLEUKIN-17; INTERLEUKIN-23; MIDDLE AGED; OSTEOARTHRITIS; PHOSPHORYLATION; RNA, MESSENGER; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; SYNOVIAL FLUID; SYNOVIAL MEMBRANE; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTOR 4; UP-REGULATION;

EID: 84893567680     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12196     Document Type: Article

References (22)

1. Brentano F, Kyburz D, Gay S. Toll-like receptors and rheumatoid arthritis. Methods Mol Biol 2009; 517:329-43.
2. Ospelt C, Neidhart M, Gay RE, Gay S. Synovial activation in rheumatoid arthritis. Front Biosci 2004; 9:2323-34.
3. Shahrara S, Huang Q, Mandelin AM 2nd, Pope RM. TH-17 cells in rheumatoid arthritis. Arthritis Res Ther 2008; 10:R93.
4. Lee JH, Cho ML, Kim JI et al. Interleukin 17 (IL-17) increases the expression of Toll-like receptor-2, 4, and 9 by increasing IL-1β and IL-6 production in autoimmune arthritis. J Rheumatol 2009; 36:684-92.
5. Paradowska-Gorycka A, Grzybowska-Kowalczyk A, Wojtecka-Lukasik E, Maslinski S. IL-23 in the pathogenesis of rheumatoid arthritis. Scand J Immunol 2010; 71:134-45.
6. Cho ML, Kang JW, Moon YM et al. STAT3 and NF-κB signal pathway is required for IL-23-mediated IL-17 production in spontaneous arthritis animal model IL-1 receptor antagonist-deficient mice. J Immunol 2006; 176:5652-61.
7. Kim HR, Kim HS, Park MK, Cho ML, Lee SH, Kim HY. The clinical role of IL-23p19 in patients with rheumatoid arthritis. Scand J Rheumatol 2007; 36:259-64.
8. Ospelt C, Brentano F, Rengel Y et al. Overexpression of toll-like receptors 3 and 4 in synovial tissue from patients with early rheumatoid arthritis: toll-like receptor expression in early and longstanding arthritis. Arthritis Rheum 2008; 58:3684-92.
9. Kim KW, Cho ML, Oh HJ, Kim HR, Kang CM, Heo YM, Lee SH, Kim HY. TLR-3 enhances osteoclastogenesis through upregulation of RANKL expression from fibroblast-like synoviocytes in patients with rheumatoid arthritis. Immunol Lett 2009; 124:9-17.
10. Kim KW, Cho ML, Lee SH et al. Human rheumatoid synovial fibroblasts promote osteoclastogenic activity by activating RANKL via TLR-2 and TLR-4 activation. Immunol Lett 2007; 110:54-64.
11. Abdollahi-Roodsaz S, Joosten LA, Koenders MI et al. Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis. J Clin Invest 2008; 118:205-16.
12. Loures FV, Pina A, Felonato M, Calich VL. TLR2 is a negative regulator of Th17 cells and tissue pathology in a pulmonary model of fungal infection. J Immunol 2009; 183:1279-90.
13. Nichols JR, Aldrich AL, Mariani MM, Vidlak D, Esen N, Kielian T. TLR2 deficiency leads to increased Th17 infiltrates in experimental brain abscesses. J Immunol 2009; 182:7119-30.
14. Hu X, Chen J, Wang L, Ivashkiv LB. Crosstalk among Jak-STAT, Toll-like receptor, and ITAM-dependent pathways in macrophage activation. J Leukoc Biol 2007; 82:237-43.
15. Hu X, Chakravarty SD, Ivashkiv LB. Regulation of interferon and Toll-like receptor signaling during macrophage activation by opposing feedforward and feedback inhibition mechanisms. Immunol Rev 2008; 226:41-56.
16. Siddiquee K, Zhang S, Guida WC et al. Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity. Proc Natl Acad Sci USA 2007; 104:7391-6.
17. Dong C. TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat Rev Immunol 2008; 8:337-48.
18. Brennan FM, McInnes IB. Evidence that cytokines play a role in rheumatoid arthritis. J Clin Invest 2008; 118:3537-45.
19. Kim HR, Cho ML, Kim KW et al. Up-regulation of IL-23p19 expression in rheumatoid arthritis synovial fibroblasts by IL-17 through PI3-kinase-, NF-κB- and p38 MAPK-dependent signalling pathways. Rheumatology (Oxford) 2007; 46:57-64.
20. Verreck FA, de Boer T, Langenberg DM et al. Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc Natl Acad Sci USA 2004; 101:4560-5.
21. Miossec P. An update on the cytokine network in rheumatoid arthritis. Curr Opin Rheumatol 2004; 16:218-22.
22. Sutmuller RP, den Brok MH, Kramer M et al. Toll-like receptor 2 controls expansion and function of regulatory T cells. J Clin Invest 2006; 116:485-94.